ID DFT2.JV AC CVCL_A1TN SY JV DR Wikidata; Q105506748 RX PubMed=26711993; RX PubMed=32937435; CC Group: Marsupial cell line. DI NCIt; C176224; Devil facial tumor disease 2 OX NCBI_TaxID=9305; ! Sarcophilus harrisii (Tasmanian devil) OI CVCL_LB80 ! DFT2.RV OI CVCL_A1YH ! DFT2.SN SX Male CA Cancer cell line DT Created: 12-01-21; Last updated: 21-03-23; Version: 3 // RX PubMed=26711993; DOI=10.1073/pnas.1519691113; PMCID=PMC4720317; RA Pye R.J., Pemberton D., Tovar Lopez C.D., Tubio J.M.C., Dun K.A., RA Fox S., Darby J.M., Hayes D., Knowles G.W., Kreiss A., Siddle H.V.T., RA Swift K., Lyons A.B., Murchison E.P., Woods G.M.; RT "A second transmissible cancer in Tasmanian devils."; RL Proc. Natl. Acad. Sci. U.S.A. 113:374-379(2016). // RX PubMed=32937435; DOI=10.1126/sciadv.aba5031; PMCID=PMC7458443; RA Flies A.S., Darby J.M., Lennard P.R., Murphy P.R., Ong C.E.B., RA Pinfold T.L., De Luca A., Lyons A.B., Woods G.M., Patchett A.L.; RT "A novel system to map protein interactions reveals evolutionarily RT conserved immune evasion pathways on transmissible cancers."; RL Sci. Adv. 6:eaba5031.1-eaba5031.13(2020). //